Literature DB >> 34289643

The potential interaction between COVID-19 vaccines and clozapine: A novel approach for clinical trials.

İzgi Bayraktar1, Nadir Yalçın1, Kutay Demirkan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34289643     DOI： 10.1111/ijcp.14441

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN： 1368-5031            Impact factor:   2.503


× No keyword cloud information.
  3 in total

1.  Elevated Clozapine Blood Concentrations After Second COVID-19 Vaccination With Spikevax (COVID-19 Vaccine Moderna).

Authors:  Christian Knöchel; Gudrun Hefner; Thomas Stiehl; Walter Schmidbauer
Journal:  J Clin Psychopharmacol       Date:  2022-01-28       Impact factor: 3.118

2.  Psychotropic drugs interaction with the lipid nanoparticle of COVID-19 mRNA therapeutics.

Authors:  Adonis Sfera; Sabine Hazan; Jonathan J Anton; Dan O Sfera; Christina V Andronescu; Sarvin Sasannia; Leah Rahman; Zisis Kozlakidis
Journal:  Front Pharmacol       Date:  2022-09-09       Impact factor: 5.988

3.  Two Patients with Schizophrenia Treated with Clozapine Developed Neutropenia After Receiving a COVID-19 Vaccine.

Authors:  Tetsu Tomita; Yui Sakamoto; Manabu Saito; Kojiro Hashimoto; Yasuki Ono; Kazuhiko Nakamura
Journal:  Int Med Case Rep J       Date:  2022-01-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.